Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Rocepafant (LAU8080) is a platelet-activating factor (PAF) antagonist that attenuates hypoxic-ischemic brain damage in neonatal rats.Rocepafant inhibits tumor necrosis factor-Afa-mediated cytotoxicity in mouse L929 tumor cells.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 17,500 | |||
5 mg | 在庫あり | ¥ 41,000 | |||
10 mg | 在庫あり | ¥ 60,000 | |||
25 mg | 在庫あり | ¥ 116,500 | |||
50 mg | 在庫あり | ¥ 158,500 | |||
100 mg | 在庫あり | ¥ 225,500 |
説明 | Rocepafant (LAU8080) is a platelet-activating factor (PAF) antagonist that attenuates hypoxic-ischemic brain damage in neonatal rats.Rocepafant inhibits tumor necrosis factor-Afa-mediated cytotoxicity in mouse L929 tumor cells. |
ターゲット&IC50 | PAF receptor:0.74 nM |
別名 | LAU 8080, LAU8080, BN 50730, LAU-8080, BN50730, BN-50730 |
分子量 | 535.08 |
分子式 | C26H23ClN6OS2 |
CAS No. | 132579-32-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (102.79 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Rocepafant 132579-32-9 Others Platelet aggregation LAU 8080 LAU8080 BN 50730 LAU-8080 BN50730 BN-50730 Inhibitor inhibitor inhibit